Tarsus Pharmaceuticals Statistics
Total Valuation
TARS has a market cap or net worth of $1.92 billion. The enterprise value is $1.70 billion.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TARS has 38.38 million shares outstanding. The number of shares has increased by 27.98% in one year.
| Current Share Class | 38.38M |
| Shares Outstanding | 38.38M |
| Shares Change (YoY) | +27.98% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 8.72% |
| Owned by Institutions (%) | 92.83% |
| Float | 29.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.63 |
| Forward PS | 5.41 |
| PB Ratio | 8.84 |
| P/TBV Ratio | 8.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.42, with a Debt / Equity ratio of 0.32.
| Current Ratio | 4.42 |
| Quick Ratio | 4.21 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.36 |
Financial Efficiency
Return on equity (ROE) is -54.83% and return on invested capital (ROIC) is -28.75%.
| Return on Equity (ROE) | -54.83% |
| Return on Assets (ROA) | -23.46% |
| Return on Invested Capital (ROIC) | -28.75% |
| Return on Capital Employed (ROCE) | -40.68% |
| Revenue Per Employee | $566,418 |
| Profits Per Employee | -$357,752 |
| Employee Count | 323 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 23.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.69% in the last 52 weeks. The beta is 1.06, so TARS's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | +37.69% |
| 50-Day Moving Average | 49.00 |
| 200-Day Moving Average | 40.03 |
| Relative Strength Index (RSI) | 53.50 |
| Average Volume (20 Days) | 642,550 |
Short Selling Information
The latest short interest is 7.40 million, so 19.29% of the outstanding shares have been sold short.
| Short Interest | 7.40M |
| Short Previous Month | 7.34M |
| Short % of Shares Out | 19.29% |
| Short % of Float | 25.36% |
| Short Ratio (days to cover) | 10.89 |
Income Statement
In the last 12 months, TARS had revenue of $182.95 million and -$115.55 million in losses. Loss per share was -$3.07.
| Revenue | 182.95M |
| Gross Profit | 116.74M |
| Operating Income | -120.57M |
| Pretax Income | -150.07M |
| Net Income | -115.55M |
| EBITDA | -119.34M |
| EBIT | -120.57M |
| Loss Per Share | -$3.07 |
Full Income StatementBalance Sheet
The company has $291.38 million in cash and $72.45 million in debt, giving a net cash position of $218.92 million or $5.70 per share.
| Cash & Cash Equivalents | 291.38M |
| Total Debt | 72.45M |
| Net Cash | 218.92M |
| Net Cash Per Share | $5.70 |
| Equity (Book Value) | 224.53M |
| Book Value Per Share | 5.85 |
| Working Capital | 276.09M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$83.03 million and capital expenditures -$1.57 million, giving a free cash flow of -$84.59 million.
| Operating Cash Flow | -83.03M |
| Capital Expenditures | -1.57M |
| Free Cash Flow | -84.59M |
| FCF Per Share | -$2.20 |
Full Cash Flow StatementMargins
Gross margin is 63.81%, with operating and profit margins of -65.90% and -63.16%.
| Gross Margin | 63.81% |
| Operating Margin | -65.90% |
| Pretax Margin | -63.16% |
| Profit Margin | -63.16% |
| EBITDA Margin | -65.23% |
| EBIT Margin | -65.90% |
| FCF Margin | n/a |
Dividends & Yields
TARS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.98% |
| Shareholder Yield | -27.98% |
| Earnings Yield | -6.02% |
| FCF Yield | -4.41% |
Analyst Forecast
The average price target for TARS is $63.67, which is 27.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $63.67 |
| Price Target Difference | 27.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 40.37% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TARS has an Altman Z-Score of 3.99 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.99 |
| Piotroski F-Score | 3 |